Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Blackstone Inc (BX) vs Medtronic PLC (MDT) Price & Performance

Blackstone IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Blackstone Inc vs Medtronic PLC — how do they compare? Blackstone Inc trades at $146.49 (market cap $113.32B), while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Blackstone Inc and Medtronic PLC are close in size by market cap, and Blackstone Inc pays the higher dividend (3.69%). Which is the better fit depends on your goals.

BXMDT
Market Cap
$113.32B$114.45B
Sector
FinancialsHealth
52-Week High
$188.68$105.35
52-Week Low
$102.12$73.75
Dividend Yield
3.69%3.22%
Enterprise Value
$133.19B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Blackstone Inc

Blackstone Inc. (BX) trades at $137.13, up 2.76% on the day, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $12.41 billion in 2025, with a net income margin of 25.85%, while analyst consensus is a Buy with a $144.00 price target. Recent news includes a $16 billion Kuwait oil pipeline deal and the acquisition of a $25.3 billion Australian loan portfolio from HSBC, highlighting strategic expansion.

The outlook for BX is positive, driven by robust earnings growth and strategic acquisitions, but risks include market volatility and sector-specific pressures. Upside potential exists toward the consensus target, though overbought RSI levels near-term may prompt consolidation.

Medtronic PLC

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Blackstone Inc

Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.

Read more on BX

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT